Skip to content

Efficacy and Safety of Milk Secretory Supplement in Breast-feeding Volunteers

Efficacy and Safety of Milk Secretory Supplement Containing Fenugreek, Banana Flower, and Ginger Extract in Breast-feeding Volunteers

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05880589
Enrollment
24
Registered
2023-05-30
Start date
2022-12-08
Completion date
2023-11-10
Last updated
2023-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lactation

Brief summary

The objective of this study are to evaluate efficacy and safety of milk secretory supplement containing fenugreek, banana flower, and ginger extract in breast-feeding volunteers

Detailed description

There are 24 volunteers in this study. They are randomly divided into 2 groups which are milk secretory supplement group and placebo group. The volunteers take 2 tablets of the sample 2 times/day for 14 days. Amount of breast milk, calcium, iron, docosahexaenoic acid, quality of life, adverse reaction, and satisfaction before taking and after taking for 14 days.

Interventions

DIETARY_SUPPLEMENTMilk secretory supplement group

Take 2 tablet 2 times per day for 14 days

DIETARY_SUPPLEMENTPlacebo group

Take 2 tablet 2 times per day for 14 days

Sponsors

Chulalongkorn University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* During lactation * Using only breast pump * No taking medicine or dietary that has an effect on milk secretary including domperidone, banana flower, fenugreek, and ginger in 48 hours * No smoking and alcohol drinking * Can read and write in Thai language * Can meet researcher at the date of appointment * No complication after delivering

Exclusion criteria

* Have uncontrolled diseases, cancer, or heart disease * Have immunocompromised disease or use steroid in 2 weeks * Allergic to fenugreek, banana flower, ginger, docosahexaenoic acid, iron, folate, and iodine * Cannot follow the protocol

Design outcomes

Primary

MeasureTime frameDescription
Amount of breast milk14 daysMeasure volume of breast milk (ml) (High volume means high efficacy)

Secondary

MeasureTime frameDescription
Iron in milk14 daysIron in milk (mg/100ml) (High amount means high efficacy)
Docosahexaenoic acid in milk14 daysDocosahexaenoic acid in milk (g/100ml) (High amount means high efficacy)
Quality of life of volunteers14 daysUse World Health Organization Quality of Life Brief - Thai questionnaire (0 to 4 scale means low to high quality of life)
Calcium in milk14 daysCalcium in milk (mg/100ml) (High amount means high efficacy)
Gastrointestinal reaction after taking supplement14 daysFound or not found
Respiratory tract reaction after taking supplement14 daysFound or not found
Satisfaction after taking supplement14 daysUse visual analogue scale (0 to 10 means lowest to highest satisfaction)
Skin reaction after taking supplement14 daysFound or not found

Countries

Thailand

Contacts

Primary ContactPornanong Aramwit, Professor
aramwit@gmail.com+66899217255

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026